9NU-80978-18368
3 vaccinations
2 coded responses
30 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 530 / WI
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
GTA-20624-90161
Child or adolescent in my care · Male · 2022-06-26
Timeline
-
2021-01-09
Dose 1 — Moderna
-
2021-01-13
Registered in v-safe
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · Muscle or body achesAdult check-in
- 2021-01-15
- 2021-01-16
-
2021-01-23
Survey response — day 14, dose 1MedDRA: Injection site bruising, Injection site erythema, Injection site pruritus, Injection site swelling — Feeling: FairFree text: Approximately 8 day post injection, resurgence of swelling and redness. Required Diphenhydramine op and topical plus hydrocortisone topical. Redness, itching, swelling resolved after additional week, leaving bruising. Bruising has not yet resolvedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — day 21, dose 1MedDRA: Injection site bruising, Injection site inflammation, Injection site pruritus — Feeling: GoodFree text: Lingering bruising post inflammation. Inflammation started again 1 week post injection and lasted for a week. It was itchy. Both inflammation and itch resolved but bruising remains despite 3 weeks since immunization.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Dose 2 — Moderna
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-20
- 2021-08-07
-
2021-10-28
Dose 3 — Pfizer-BioNTech
- 2021-10-28
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2022-01-27
- 2022-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Moderna | |
| 2 | 2021-02-06 | Moderna | |
| 3 | 2021-10-28 | Pfizer-BioNTech | No |
Free text
Release 2 — day 14, dose 1
Symptoms: Approximately 8 day post injection, resurgence of swelling and redness. Required Diphenhydramine op and topical plus hydrocortisone topical. Redness, itching, swelling resolved after additional week, leaving bruising. Bruising has not yet resolved cut off by CDC
Release 3 — day 21, dose 1
Symptoms: Lingering bruising post inflammation. Inflammation started again 1 week post injection and lasted for a week. It was itchy. Both inflammation and itch resolved but bruising remains despite 3 weeks since immunization.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site bruising | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site inflammation | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release